reason report
ci pois strong deal close question
bottom line reiter high convict buy call ci
compani receiv last approv state
nj esrx transact today set stage
transact close tomorrow rais pt
price-to-earnings ep price-to-earnings
ep high regard ceo david
cordani manag team across eric palmer cfo
oper leadership matt mander brian evanko see
tim wentworth guid hand essenti success oper
organiz cultur integr two compani
expect potenti solid ep upsid consensu estim
go forward see key question manag
pace synergi guid
mm admin cost save lead ep
upsid addit possibl front load
potenti medic cost synergi
offer quantit guidanc use compet
cvs-aet optum rx cross sell bundl
medic pharmaci benefit market segment
chang go-to-market strategi
cross sell play toward blend revenu growth
oper organiz cultur challeng
success integr across two compani
mileston goal post investor look track
progress integr ctrx-optum rx contract
play esrx integr
plan capit deploy time debt pay
much combin compani gener
right number annual ci begin invest care deliveri
home health primari care compet
competitor time
given scarciti primari care home health well care
pleas see recent call offer strateg financi
driver ci combin esrx along work merg
forma ep
net debt total capit
price-to-earnings lt ep growth
share outstand mil share outstand
estimate lt ep growth compound-annual-growth-rate
year price history/av daili volume mil ci
compani inform leerink partner llc research
revenu ep forma ci-esrx ex-antm
revenu billion ep exclud item non-gaap ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
reiter high convict buy call ci compani receiv last
approv state nj esrx transact today set stage
transact close tomorrow rais pt price-to-earnings
ep price-to-earnings ep high regard
ceo david cordani manag team across eric palmer cfo
oper leadership matt mander brian evanko see tim wentworth guid
hand essenti success oper organiz cultur integr two
compani expect potenti solid ep upsid consensu estim
reiter strong convict ci deep valu name compel valuat
price-to-earnings adjust pro forma ep expect strongli accret deal
drive posit revis beyond unlock valu next month
pt base pro forma ep ex-
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak member
util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership top
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
inc ci incom mail order pharmaci invest invest gain revenu expenseshealth care medic claim benefit mail order pharmaci cost good acquisit oper expens exclud special deal synergi benefit continu oper incom tax net net incom ep growth metricstot adj gdr gener dispens ep corpor
health enrol access/oth guarante guarante legaci servic great west medic membership without medic membership medic membership gw corpor
cigna inc ci million oper activitiesnet discontinu polici acquisit account note payabl accru expens incom incom proce flow oper flow invest activitiesproce contracthold deposit fund overdraft common stock net flow financ foreign exchang increas decreas corpor
ana gupt ph certifi view express report accur reflect view part
compens directli relat specif recommend view contain report
risk valuat
non-profit bcb plan insur price irrat commerci market rapidli acceler medic
medic cost trend come higher anticip potenti econom downturn provid re-up
intens servic deliveri cobra acceler uptak member util care advanc layoff
employ exit rapidli sponsorship health benefit combat medic cost inflat catalyz
econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti underwrit margin
longer term state-bas insur exchang advers select reduc sustain earn power
employ dump employe health insur
exchang signific margin compress potenti downsid membership top line also present
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund compani
pension oblig polit legal oper regulatori econom risk foreign oper
distribut ratings/invest bank servic ib
explan rate
outperform buy expect stock outperform benchmark next month
market perform hold/neutr expect stock perform line benchmark next
under-perform sell expect stock under-perform benchmark next month
degre out-performance under-perform requir warrant outperform under-perform
rate commensur risk profil compani
purpos definit relev benchmark issuer
market capit less billion issuer market
capit billion
